0306-03
Showing 1 - 25 of 335
B-cell Non-Hodgkin's Lymphoma Trial (IMM0306, Lenalidomide capsule)
Not yet recruiting
- B-cell Non-Hodgkin's Lymphoma
- IMM0306
- Lenalidomide capsule
- (no location specified)
Mar 6, 2023
CD20-positive B-cell Non-Hodgkin's Lymphoma Trial in Beijing (IMM0306)
Recruiting
- CD20-positive B-cell Non-Hodgkin's Lymphoma
-
Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Apr 6, 2023
Advanced Solid Tumor, Cutaneous T Cell Lymphoma Trial in Guanzhou (SIM1811-03)
Recruiting
- Advanced Solid Tumor
- Cutaneous T Cell Lymphoma
-
Guanzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Mar 10, 2023
Idiopathic Pulmonary Fibrosis Trial in London (LTI-03, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- LTI-03
- Placebo
-
London, United KingdomStudy Site
Jul 18, 2023
Following Transcutaneous Auricular Neurostimulation to Improve
Not yet recruiting
- Opioid Use Disorder
- Relapse
- Clinical Outcomes and Questionnaires
-
Rancho Mirage, California
- +1 more
Oct 25, 2022
Protocol CAUSE-03 / CHEETAH
Not yet recruiting
- Asthma
-
Aurora, Colorado
- +6 more
Nov 15, 2023
iMmune SignAtures and Clinical outComes in AP
Recruiting
- Acute Pancreatitis
- CyTOF Analysis
-
Los Angeles, California
- +4 more
May 17, 2023
Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)
Recruiting
- Advanced Solid Tumor
- Cutaneous T-cell Lymphoma (CTCL)
-
Detroit, Michigan
- +5 more
Oct 6, 2022
Adolescent Lupus Nephritis Trial in Orlando (voclosporin)
Not yet recruiting
- Adolescent Lupus Nephritis
-
Orlando, FloridaNemours Children's Health, Lake Nona Medical City
Jul 18, 2023
Total Joint Arthroplasty in a Pediatric Population
Recruiting
- Total Joint Arthroplasty
-
Aurora, ColoradoChildren's Hospital Colorado
Apr 27, 2022
Tumor Trial in Shanghai (SIBP-03)
Recruiting
- Tumor
- SIBP-03
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 23, 2022
Duchenne Muscular Dystrophy Trial (NS-050/NCNP-03, Placebo)
Not yet recruiting
- Duchenne Muscular Dystrophy
- NS-050/NCNP-03
- Placebo
- (no location specified)
Sep 19, 2023
Blepharitis Trial in United States (TP-03, 0.25%, TP-03 Vehicle)
Completed
- Blepharitis
- TP-03, 0.25%
- TP-03 Vehicle
-
Phoenix, Arizona
- +14 more
Jul 7, 2022
Haemodialysis Outcomes & Patient Empowerment Study 03
Recruiting
- Volume Overload
- Dialysis
-
Dublin, Leinster, Ireland
- +1 more
Feb 20, 2023
Gastric Cancer Trial
Completed
- Gastric Cancer
- (no location specified)
Dec 20, 2022
Meibomian Gland Dysfunction, Blepharitis, Demodex Infestation Trial (TP-03, TP-03 Vehicle)
Not yet recruiting
- Meibomian Gland Dysfunction
- +2 more
- TP-03
- TP-03 Vehicle
- (no location specified)
Jul 13, 2022
Amyloidosis; Systemic Trial in Knoxville (124I-AT03)
Recruiting
- Amyloidosis; Systemic
-
Knoxville, TennesseeUniversity of Tennessee Medical Center
Mar 14, 2022
Influenza, Influenza Immunization Trial in United States (Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant
Completed
- Influenza
- Influenza Immunization
- Influenza Hemagglutinin mRNA vaccine
- Quadrivalent Recombinant Influenza Vaccine
-
Rolling Hills Estates, California
- +19 more
Oct 31, 2023
Idiopathic Pulmonary Fibrosis Trial in Belfast (Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03), Placebo)
Completed
- Idiopathic Pulmonary Fibrosis
- Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03)
- Placebo
-
Belfast, United KingdomCelerion
Mar 4, 2022
Healthy Trial in Mount Royal (TP-03 (Lotilaner Ophthalmic Solution), 0.25%)
Active, not recruiting
- Healthy
- TP-03 (Lotilaner Ophthalmic Solution), 0.25%
-
Mount Royal, Quebec, CanadaAltasciences
Nov 17, 2021
Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS) Trial in France, United States (Sutimlimab)
Recruiting
- Cold Agglutinin Disease (CAD)
- Cold Agglutinin Syndrome (CAS)
-
Birmingham, Alabama
- +7 more
Mar 28, 2023